These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 21785119)

  • 1. Ciprofloxacin safety in paediatrics: a systematic review.
    Adefurin A; Sammons H; Jacqz-Aigrain E; Choonara I
    Arch Dis Child; 2011 Sep; 96(9):874-80. PubMed ID: 21785119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of ciprofloxacin in children: worldwide clinical experience based on compassionate use. Emphasis on joint evaluation.
    Chyský V; Kapila K; Hullmann R; Arcieri G; Schacht P; Echols R
    Infection; 1991; 19(4):289-96. PubMed ID: 1917049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotics for induction and maintenance of remission in Crohn's disease.
    Townsend CM; Parker CE; MacDonald JK; Nguyen TM; Jairath V; Feagan BG; Khanna R
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD012730. PubMed ID: 30731030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ciprofloxacin use: acute arthropathy and long-term follow up.
    Karande S; Kshirsagar NA
    Indian Pediatr; 1996 Nov; 33(11):910-6. PubMed ID: 9141825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of ciprofloxacin use in children.
    Okoye NV; Oyawole MR; Uzochukwu PU; Oyetunde OO
    Nig Q J Hosp Med; 2013; 23(1):43-7. PubMed ID: 24579494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ciprofloxacin safety in a pediatric population.
    Jick S
    Pediatr Infect Dis J; 1997 Jan; 16(1):130-3; discussion 133-4, 160-2. PubMed ID: 9002123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotics for the prevention of pediatric antibiotic-associated diarrhea.
    Goldenberg JZ; Lytvyn L; Steurich J; Parkin P; Mahant S; Johnston BC
    Cochrane Database Syst Rev; 2015 Dec; (12):CD004827. PubMed ID: 26695080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ciprofloxacin in children: is arthropathy a limitation?
    Singh UK; Sinha RK; Prasad B; Chakrabarti B; Sharma SK
    Indian J Pediatr; 2000 May; 67(5):386-7. PubMed ID: 10885214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of ceftriaxone in paediatrics: a systematic review.
    Zeng L; Wang C; Jiang M; Chen K; Zhong H; Chen Z; Huang L; Li H; Zhang L; Choonara I
    Arch Dis Child; 2020 Oct; 105(10):981-985. PubMed ID: 32144089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised comparison of ciprofloxacin suspension and pivmecillinam for childhood shigellosis.
    Salam MA; Dhar U; Khan WA; Bennish ML
    Lancet; 1998 Aug; 352(9127):522-7. PubMed ID: 9716056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ciprofloxacin use in neonates: a systematic review of the literature.
    Kaguelidou F; Turner MA; Choonara I; Jacqz-Aigrain E
    Pediatr Infect Dis J; 2011 Feb; 30(2):e29-37. PubMed ID: 21048525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do fluoroquinolones commonly cause arthropathy in children?
    Forsythe CT; Ernst ME
    CJEM; 2007 Nov; 9(6):459-62. PubMed ID: 18072993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of fluconazole in paediatrics: a systematic review.
    Egunsola O; Adefurin A; Fakis A; Jacqz-Aigrain E; Choonara I; Sammons H
    Eur J Clin Pharmacol; 2013 Jun; 69(6):1211-21. PubMed ID: 23325436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotics for preventing lower respiratory tract infections in high-risk children aged 12 years and under.
    Onakpoya IJ; Hayward G; Heneghan CJ
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD011530. PubMed ID: 26408070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ciprofloxacin during upper respiratory tract infections to reduce Pseudomonas aeruginosa infection in paediatric cystic fibrosis: a pilot study.
    Connett GJ; Pike KC; Legg JP; Cathie K; Dewar A; Foote K; Harris A; Faust SN
    Ther Adv Respir Dis; 2015 Dec; 9(6):272-80. PubMed ID: 26341118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerance and safety of ciprofloxacin in paediatric patients.
    Black A; Redmond AO; Steen HJ; Oborska IT
    J Antimicrob Chemother; 1990 Dec; 26 Suppl F():25-9. PubMed ID: 2292542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and tolerability of linezolid in children.
    Saiman L; Goldfarb J; Kaplan SA; Wible K; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S193-200. PubMed ID: 14520146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. ceftazidime/tobramycin in the treatment of acute pulmonary exacerbations. The Cystic Fibrosis Study Group.
    Church DA; Kanga JF; Kuhn RJ; Rubio TT; Spohn WA; Stevens JC; Painter BG; Thurberg BE; Haverstock DC; Perroncel RY; Echols RM
    Pediatr Infect Dis J; 1997 Jan; 16(1):97-105; discussion 123-6. PubMed ID: 9002118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cochrane Review: Osmotic and stimulant laxatives for the management of childhood constipation (Review).
    Gordon M; Naidoo K; Akobeng AK; Thomas AG
    Evid Based Child Health; 2013 Jan; 8(1):57-109. PubMed ID: 23878124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciprofloxacin as a therapeutic modality in pediatric burn wound infections: efficacious or contraindicated?
    Heggers JP; Villarreal C; Edgar P; Wolf S; Klein GL; John SD; Desai M; Herndon DN
    Arch Surg; 1998 Nov; 133(11):1247-50. PubMed ID: 9820358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.